Nanochap Technology Leads Innovation: Three New Electrical Stimulation Modules for Wireless, Portable and Precision Medical Needs

At the intersection of neuroscience and medical technology, Nanochap continues to push the boundaries of neurostimulation with its deep expertise and relentless innovation. From the initial launch of NS4 chip, to the upgraded iteration of ENS001, to the successful launch of Nanochap's NNC6121 chip in 2024, Nanochap's dedication to precision medicine and efficient treatment has been evident in every step of the way. Meanwhile, in order to meet the market demand more comprehensively, Nanochap has launched three innovative electrical stimulation modules based on the development of NNC6121 chip, which has injected new vitality into the field of medical devices.

Neurostimulation Chip Development History

NS4 chip

As the pioneer of Nanochap's neurostimulation chips, the NS4 chip has set a new benchmark in the field of neurostimulation with its stable electrical stimulation performance and excellent constant current source technology.

ENS001 chip

Nanochap introduced the ENS001 chip based on the NS4, which improves the integration and efficiency of electrical stimulation management while maintaining the original stable performance. This makes the neurostimulation device more compact and portable, and brings users a more comfortable and efficient treatment experience.

NNC6121 Chip

In 2024, Nanochap launched the new NNC6121 chip. While maintaining the excellent performance of ENS001, its streamlined design and excellent performance are suitable for a wide range of application scenarios, and it meets the needs of users at an affordable price, making it the preferred solution in the field of electrical stimulation.

Electrical stimulation module innovation launched

In order to more comprehensively meet the market demand, Nanochap has now launched three new electric stimulation modules. These modules cover medical devices that require wireless control, portable or remote adjustments, precision medical devices with multiple independently controlled channels, and medical devices that require high levels of safety and stability.

1. Programmable Universal Stimulation Module - NCC6121MH

- Power supply: Isolated power supply ensures high safety and anti-interference capability.

- Intelligent control: support wireless configuration, compatible with upper computer and small program, flexible adjustment of parameters.

- Stimulate high current: dual-channel merged output is available to provide higher drive current and adapt to more complex application scenarios.

- Applicable scenarios: medical devices that require wireless control, portable or remote adjustment, such as rehabilitation therapies, wearable stimulation devices, etc.

2. Programmable Universal Stimulation Module - NCC6121MI

- Power supply: Isolated power supply ensures high safety and anti-interference capability.

- Dual-chip architecture: Built-in two stimulation chips, can output two different waveforms at the same time to meet the demand of multi-target stimulation.

- Intelligent control: support wireless configuration, compatible with the upper computer and small program, flexible adjustment of parameters.

- Output channels: single-channel, dual-channel, dual-channel mutual isolation, current independent adjustable. Also support dual-channel merger to enhance the output capacity.

- Applicable scenarios: Precision medical equipment requiring independent control of multiple channels, such as neurophysiology research, multi-site synchronized therapy instrument, etc.

3. Programmable Universal Stimulation Module - NCC6121MK

- Transformer output design: signal isolation is realized through transformer to ensure high safety and anti-interference ability.

- Intelligent control: can be configured directly through the upper computer on the computer side to meet the integration needs of professional medical equipment.

- Output channels: dual channels are isolated from each other, and the current is independently adjustable.

- Applicable scenarios: medical equipment with high requirements for safety and stability, such as surgical assisted stimulators and high-precision rehabilitation therapy systems.

From NS4 to ENS001 to NNC6121, Nanochap's development in the field of neurostimulation has witnessed its magnificent transformation from laying the foundation stone to technological upgrading, and then to innovation leading. Meanwhile, the launch of three new electrical stimulation modules further enriches Nanochap's medical device product line.

Company Introduction

Nanochap, a medical chip research enterprise integrating R&D, production and sales, continues to drive the progress of medical and healthcare technology with its outstanding mass production capability and advanced factories. The company gathers top electronic engineers and biomedical engineers, focusing on the deep excavation and wide application of biochip technology. Nanochap has now passed ISO 13485 quality system certification and ISO 9001 quality system certification, and strictly controls every production process to ensure product quality meets standards. In addition, the company has been recognized as a national specialized, special and new “small giant” enterprise, further consolidating its leading position in the industry.

Contact Us

Overseas: 

+61432800985 (Melbourne)

+84967096581 (Ho Chi Minh city)

E-mail: 

lliugen.lin@nanochap.com

Address：

Suite 3, Level 4,10 Queens road,Melbourne, VC 3004, Australia.

Level 19,TTc Building, 253 Hoang Van Thu,Ward 2, Tan Binh District, Ho Chi Minh cityVietnam.